241 related articles for article (PubMed ID: 19207479)
1. Resting heart rate does not reflect the degree of beta-blockade in subjects with heart failure on chronic beta-blocker therapy.
Mignatti A; Sims DB; Colombo PC; Garcia LI; Bijou R; Deng MC; Jorde UP
Cardiovasc Ther; 2009; 27(1):42-8. PubMed ID: 19207479
[TBL] [Abstract][Full Text] [Related]
2. About "Resting heart rate does not reflect the degree of beta-blockade in subjects with heart failure on chronic beta-blocker therapy".
Carvalho VO
Cardiovasc Ther; 2009; 27(3):221. PubMed ID: 19689621
[No Abstract] [Full Text] [Related]
3. Effect of β-blocker cessation on chronotropic incompetence and exercise tolerance in patients with advanced heart failure.
Hirsh BJ; Mignatti A; Garan AR; Uriel N; Colombo P; Sims DB; Jorde UP
Circ Heart Fail; 2012 Sep; 5(5):560-5. PubMed ID: 22855557
[TBL] [Abstract][Full Text] [Related]
4. Chronotropic incompetence, beta-blockers, and functional capacity in advanced congestive heart failure: time to pace?
Jorde UP; Vittorio TJ; Kasper ME; Arezzi E; Colombo PC; Goldsmith RL; Ahuja K; Tseng CH; Haas F; Hirsh DS
Eur J Heart Fail; 2008 Jan; 10(1):96-101. PubMed ID: 18096432
[TBL] [Abstract][Full Text] [Related]
5. What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? Experiences from the Metoprolol Controlled Release/Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF).
Gullestad L; Wikstrand J; Deedwania P; Hjalmarson A; Egstrup K; Elkayam U; Gottlieb S; Rashkow A; Wedel H; Bermann G; Kjekshus J;
J Am Coll Cardiol; 2005 Jan; 45(2):252-9. PubMed ID: 15653024
[TBL] [Abstract][Full Text] [Related]
6. Short-term improvement in submaximal exercise capacity by optimized therapy with ACE inhibitors and beta blockers in heart failure patients is associated with restoration of peripheral endothelial function.
Poelzl G; Frick M; Lackner B; Huegel H; Alber HF; Mair J; Herold M; Schwarzacher SP; Pachinger O; Weidinger F
Int J Cardiol; 2006 Mar; 108(1):48-54. PubMed ID: 16516697
[TBL] [Abstract][Full Text] [Related]
7. Chronic heart failure, chronotropic incompetence, and the effects of beta blockade.
Witte KK; Cleland JG; Clark AL
Heart; 2006 Apr; 92(4):481-6. PubMed ID: 16159968
[TBL] [Abstract][Full Text] [Related]
8. Effect of baseline or changes in adrenergic activity on clinical outcomes in the beta-blocker evaluation of survival trial.
Bristow MR; Krause-Steinrauf H; Nuzzo R; Liang CS; Lindenfeld J; Lowes BD; Hattler B; Abraham WT; Olson L; Krueger S; Thaneemit-Chen S; Hare JM; Loeb HS; Domanski MJ; Eichhorn EJ; Zelis R; Lavori P
Circulation; 2004 Sep; 110(11):1437-42. PubMed ID: 15337700
[TBL] [Abstract][Full Text] [Related]
9. Heart rate reduction and exercise performance in recent onset heart failure with reduced ejection fraction: arguments for beta-blocker hypo-response.
Verbrugge FH; Vrijsen J; Vercammen J; Grieten L; Dupont M; Mullens W
Acta Cardiol; 2015 Oct; 70(5):565-72. PubMed ID: 26567816
[TBL] [Abstract][Full Text] [Related]
10. The carvedilol's beta-blockade in heart failure and exercise training's sympathetic blockade in healthy athletes during the rest and peak effort.
Carvalho VO; Bocchi EA; Guimarães GV
Cardiovasc Ther; 2010 Apr; 28(2):87-92. PubMed ID: 20398097
[TBL] [Abstract][Full Text] [Related]
11. Surrogate end points in heart failure trials.
Gheorghiade M; Adams KF; Gattis WA; Teerlink JR; Orlandi C; O'Connor CM
Am Heart J; 2003 Feb; 145(2 Suppl):S67-70. PubMed ID: 12594457
[No Abstract] [Full Text] [Related]
12. Gly389Arg polymorphism of beta1-adrenergic receptor is associated with the cardiovascular response to metoprolol.
Liu J; Liu ZQ; Tan ZR; Chen XP; Wang LS; Zhou G; Zhou HH
Clin Pharmacol Ther; 2003 Oct; 74(4):372-9. PubMed ID: 14534524
[TBL] [Abstract][Full Text] [Related]
13. Impact of ''off-label'' use of ivabradine on exercise capacity, gas exchange, functional class, quality of life, and neurohormonal modulation in patients with ischemic chronic heart failure.
Sarullo FM; Fazio G; Puccio D; Fasullo S; Paterna S; Novo S; Di Pasquale P
J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4):349-55. PubMed ID: 20940450
[TBL] [Abstract][Full Text] [Related]
14. Predicting maximum heart rate among patients with coronary heart disease receiving beta-adrenergic blockade therapy.
Brawner CA; Ehrman JK; Schairer JR; Cao JJ; Keteyian SJ
Am Heart J; 2004 Nov; 148(5):910-4. PubMed ID: 15523326
[TBL] [Abstract][Full Text] [Related]
15. Chronic L-arginine supplementation enhances endurance exercise tolerance in heart failure patients.
Doutreleau S; Mettauer B; Piquard F; Rouyer O; Schaefer A; Lonsdorfer J; Geny B
Int J Sports Med; 2006 Jul; 27(7):567-72. PubMed ID: 16802253
[TBL] [Abstract][Full Text] [Related]
16. Analysis of randomized controlled trials on the effect of magnitude of heart rate reduction on clinical outcomes in patients with systolic chronic heart failure receiving beta-blockers.
Flannery G; Gehrig-Mills R; Billah B; Krum H
Am J Cardiol; 2008 Mar; 101(6):865-9. PubMed ID: 18328855
[TBL] [Abstract][Full Text] [Related]
17. beta-Blocker therapy for congestive heart failure: clinical considerations.
Kamath SA; Yancy CW
Postgrad Med; 2005 Dec; 118(6 Suppl Beta-Blockers):12-20. PubMed ID: 19667706
[TBL] [Abstract][Full Text] [Related]
18. Improvement in heart rate turbulence as a measure of response to beta-blocker therapy for heart failure.
Saxon LA
J Cardiovasc Electrophysiol; 2004 Jul; 15(7):757-8. PubMed ID: 15250857
[No Abstract] [Full Text] [Related]
19. [Significance of the changes of plasma endothelin, norepinephrine and atrial natriuretic peptide in treatment of heart failure with beta-blocker].
Li G; Xie X; Zhou H; Huang Y
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(5):448-50. PubMed ID: 12080680
[TBL] [Abstract][Full Text] [Related]
20. The merit of beta(1)-blockade in heart failure.
Fagerberg B
Eur Heart J; 1999 Dec; 20(24):1761-3. PubMed ID: 10581129
[No Abstract] [Full Text] [Related]
[Next] [New Search]
